RU93052163A - (S) - (+) - HYDROXYCHLOROCHINE AND TREATMENT COMPOSITION - Google Patents

(S) - (+) - HYDROXYCHLOROCHINE AND TREATMENT COMPOSITION

Info

Publication number
RU93052163A
RU93052163A RU93052163/14A RU93052163A RU93052163A RU 93052163 A RU93052163 A RU 93052163A RU 93052163/14 A RU93052163/14 A RU 93052163/14A RU 93052163 A RU93052163 A RU 93052163A RU 93052163 A RU93052163 A RU 93052163A
Authority
RU
Russia
Prior art keywords
hydroxychloroquine
hydroxychlorochine
treatment composition
compound
treatment
Prior art date
Application number
RU93052163/14A
Other languages
Russian (ru)
Inventor
Йоханна Стечер Вера
Фрэнсиз Мичне Вильям
Original Assignee
Стерлинг Уинтроп Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Стерлинг Уинтроп Инк. filed Critical Стерлинг Уинтроп Инк.
Publication of RU93052163A publication Critical patent/RU93052163A/en

Links

Claims (1)

В изобретении предлагается (S) - (+) - гидроксихлорохин, в значительной степени свободный от (R) - (-) - гидроксихлорохина, или его фармацевтически приемлемая соль, использование указанного соединения в производстве медикаментов для лечения малярии, систематической или хронической красной волчанки и ревматоидного артрита и содержащий указанное соединение состав для лечения указанных болезней. Массовое отношение (S) - (+) - гидроксихлорохина к (R) - (-) гидроксихлорохину предпочтительно составляет по крайней мере 90:10, наиболее предпочтительно 98:2.The invention provides (S) - (+) - hydroxychloroquine substantially free of (R) - (-) - hydroxychloroquine, or a pharmaceutically acceptable salt thereof, using the compound in the manufacture of a medicament for the treatment of malaria, systemic or chronic lupus erythematosus, and rheumatoid arthritis and a composition containing said compound for treating said diseases. The mass ratio of (S) - (+) - hydroxychloroquine to (R) - (-) hydroxychloroquine is preferably at least 90:10, most preferably 98: 2.
RU93052163/14A 1992-09-15 1993-09-14 (S) - (+) - HYDROXYCHLOROCHINE AND TREATMENT COMPOSITION RU93052163A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/945032 1992-09-15

Publications (1)

Publication Number Publication Date
RU93052163A true RU93052163A (en) 1997-01-27

Family

ID=

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2530605C2 (en) * 2009-06-23 2014-10-10 О-Ёног ЁО Composition for injections, which contains hydroxychloroquine, for local application in treatment of haemorrhoid

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2530605C2 (en) * 2009-06-23 2014-10-10 О-Ёног ЁО Composition for injections, which contains hydroxychloroquine, for local application in treatment of haemorrhoid

Similar Documents

Publication Publication Date Title
FI934051A (en) (S) - (+) - hydroxiklorokin
EP0217206A3 (en) Medicament against chronic graft-versus-host diseases, as well as against autoimmune diseases, particularly systemic lupus erythematodes
GB2206788B (en) 5 ht-3 antagonist for the treatment or reduction of dependence
GR3007251T3 (en)
IT8621358A0 (en) PHARMACEUTICAL COMPOSITION ANALGESIC ADAPTIVITY.
CA2163361A1 (en) Therapeutic substituted guanidines
DK0389035T3 (en) Pharmaceutical composition containing a pharmaceutically suitable carrier and the compound of structure (7alpha, 17alpha) -17-hydroxy-7-methyl-19-nor-17-pregn-5- (10) -en-20-yn-3-one
DK174289D0 (en) USE OF 3-SUBSTITUTED 2-OXINDOL-1-CARBOXAMIDE COMPOUNDS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS FOR THE REPRESENTATION OF T-CELL FUNCTION
NZ223594A (en) Crystallised cephem-acid addition salt and pharmaceutical composition
IT1271567B (en) PROCEDURE FOR THE FURTHER TREATMENT OF SALCICCE
RU93052163A (en) (S) - (+) - HYDROXYCHLOROCHINE AND TREATMENT COMPOSITION
FR2625507B1 (en) PROCESS FOR THE PREPARATION OF A COPOLYMER OF TWO ACIDS (ALPHA) -AMINES AND COPOLYMER THUS OBTAINED
ITMI931371A1 (en) PROCEDURE FOR THE PREPARATION OF ERDOSTEIN
IE840198L (en) Therapeutic use of nafazatrom
FR2602679B1 (en) NOVEL PHARMACEUTICAL COMPOSITIONS CONTAINING A GLUCAGON FRAGMENT, AND THE PREPARATION OF SUCH A FRAGMENT, AS A CALCIUM ION MOVEMENT REGULATING ACTIVE INGREDIENT
IT8420712A1 (en) "Treatment of herpetic infections"
IT8720229A0 (en) PHARMACEUTICAL COMPOSITIONS SPASMOLYTIC ADAPTIVITY CONTAINING IDANPRAMINE AS THE ACTIVE PRINCIPLE
RO88840A2 (en) NGO FOR THE TREATMENT OF ANGINE CRISES
DZ1358A1 (en) Composition for the treatment of leishmaniasis.
IT8622051A0 (en) PHARMACEUTICAL COMPOSITIONS HEALING ADAPTIVITY.
FR2604626B1 (en) LIQUID COMPOSITION HAVING SNORING VIRTUES
IT8719390A0 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS.
ITMI931174A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF THALASSEMIA
IL86116A0 (en) Pharmaceutical compositions for the treatment of malaria
BR8702295A (en) LOTTERY OF "SCORES"